Aerie Pharmaceuticals, Inc.
USD15.25
+0.00 (+0.00%)
CEO
Vicente Anido
IPO Date
2013-10-25
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$15.24
Prev. Close
$15.25
Day Low
$15.24
Day High
$15.25
52W Low
$4.81
52W High
$15.37
Volume
1.22M
| -3.4 |
| 31 Dec 2019 | FY | 93.1% | -285.6% | -119.5% | -44.1% | 1.16 | 4.50 | -5.5 |
| 31 Dec 2018 | FY | 97.3% | -961.8% | -102.1% | -81.6% | 0.00 | 4.34 | -6.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -107.0% | -50.0% | 0.91 | 10.09 | -14.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -94.0% | -39.9% | 1.17 | 12.27 | -11.1 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -396.1% | -46.7% | 6.56 | 8.09 | -8.4 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -171.6% | -29.9% | 4.43 | 15.87 | -14.6 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -46.5% | -44.2% | 0.00 | 20.18 | -11.2 |
| 31 Dec 2012 | FY | 0.0% | 0.0% | 495.8% | -465.3% | -0.77 | 0.80 | -11.2 |
| -4.6 |
| 31 Mar 2022 | Q1 | 77.3% | -120.3% | 28.6% | -9.1% | -2.68 | 2.75 | -3.0 |
| 31 Dec 2021 | Q4 | 94.7% | 39.7% | -262.7% | 10.6% | -15.04 | 2.85 | 1.8 |
| 30 Sept 2021 | Q3 | 73.1% | -135.4% | 54.5% | -11.3% | -3.49 | 2.34 | -3.3 |
| 30 Jun 2021 | Q2 | 77.3% | -142.3% | 97.7% | -10.9% | -5.96 | 2.67 | -4.8 |
| 31 Mar 2021 | Q1 | 70.8% | -182.7% | 404.7% | -11.6% | -22.19 | 3.14 | -4.9 |
| 31 Dec 2020 | Q4 | 73.5% | -186.9% | -192.5% | -11.5% | 8.98 | 3.18 | -3.4 |
| 30 Sept 2020 | Q3 | 73.2% | -197.4% | -66.0% | -10.8% | 3.49 | 3.33 | -3.4 |
| 30 Jun 2020 | Q2 | 59.4% | -267.2% | -53.7% | -12.5% | 2.28 | 3.73 | -3.5 |